The association between smoking abstinence and mortality in the national lung screening trial

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 5, 2016, Pages 534-541

  Tanner, Nichole T ^a,b   Kanodra, Neeti M ^a   Gebregziabher, Mulugeta ^a,b   Payne, Elizabeth ^a   Halbert, Chanita Hughes ^a,b   Warren, Graham W ^a   Egede, Leonard E ^a,b   Silvestri, Gerard A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Early detection of cancer; Lung neoplasms; Smoking cessation; Tobacco

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SELF REPORT; SMOKING; SMOKING CESSATION; THORAX RADIOGRAPHY; AGED; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER DIAGNOSIS; KAPLAN MEIER METHOD; LUNG; LUNG NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; SMOKING; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84973874708     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201507-1420OC     Document Type: Article

References (34)

1. World Health Organization. The top 10 causes of death: fact sheet no. 310. [updated 2014 May; accessed 2015 Jun 1]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/.
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013 [accessed 2015 May 27]. Available from: http://globocan.iarc.fr
3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-1907.
4. World Health Organization. Global Health Observatory Data (GHO). Prevalence of tobacco use. [accessed 2015 Jun 8]. Available from: http://www.who.int/gho/tobacco/use/en/.
5. Jamal A, Agaku IT, O?Connor E, King BA, Kenemer JB, Neff L; Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb Mortal Wkly Rep 2014;63:1108-1112.
6. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365: 395-409.
7. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
8. Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM. Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012;21: 1049-1059.
9. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-874.
10. UK National Screening Committee. The UK NSC recommendation on lung cancer screening in adult cigarette smokers. [accessed 2015 Jun 7]. Available from: http://www.screening.nhs.uk/lungcancer.
11. Canadian Task Force on Preventive Health Care. Protocol: screening for lung cancer. [accessed 2015 June 7]. Available from: http://canadiantaskforce.ca/ctfphc-guidelines/2015-lung-cancer/protocol/.
12. Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS). ESR/ERS white paper on lung cancer screening. Eur Respir J 2015;46:28-39.
13. Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015;147:295-303.
14. Centers for Medicare and Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT); 2015 [accessed 2015 Mar 14]. Available from: http://www.cms.gov/medicare-coverage-database/details/nca-proposeddecision-memo.aspx?NCAId=274&bc=AiAAAAAAAgAAAA%3d%3d&.
15. Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study. Cancer Epidemiol Biomarkers Prev 2013;22:2404-2411.
16. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
17. Kanodra NM, Payne E, Gebregziabher M, Egede LE, Silvestri GA, Tanner NT. Mortality risk associated with smoking in the National Lung Screening Trial (NLST) [abstract]. Am J Respir Crit Care Med 2015;191:A6116.
18. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, et al.; National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
19. US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
20. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-350.
21. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, Ockene JK, Prentice RL, Speizer FE, Thun MJ, et al. Smoking and mortality: beyond established causes. N Engl J Med 2015;372: 631-640.
22. Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol 2014;15: e568-e580.
23. Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, Wain JC, Lynch TJ, Christiani DC. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 2006;53:375-380.
24. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T; Agency for Health Care Policy and Research. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997;278:1759-1766.
25. Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, et al.; National Lung Screening Trial Research Team. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl JMed 2014; 371:1793-1802.
26. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Costeffectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-1848.
27. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010; 65:600-605.
28. Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 2014;106:dju084.
29. van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer 2012;76:204-210.
30. 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008;53:1217-1222.
31. Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev2014;23:3-9.
32. Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, Dibaj S, Herbst R, Dresler C; IASLC Tobacco Control and Smoking Cessation Committee. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol 2013;8: 543-548.
33. Studts JL, Ghate SR, Gill JL, Studts CR, Barnes CN, LaJoie AS, Andrykowski MA, LaRocca RV. Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006; 15:1825-1828.
34. Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF. The relations between false positive and negative screens and smoking cessation and relapse in the National Lung Cancer Screening Trial: implications for public health. Nicotine Tob Res 2016;18:17-24.